Concepedia

Suppression of LSD1 enhances the cytotoxic and apoptotic effects of regorafenib in hepatocellular carcinoma cells

Lin‐wen Wu, Dongmei Zhou, Zuoyan Zhang, Jiankang Zhang, Huajian Zhu, Chong Zhang

Biochemical and Biophysical Research Communications · 2019 · 22 citations · 10 references

DOI

Concepts

References

10

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

Darshan S. Chandrashekar, Bhuwan Bashel, Sai Akshaya Hodigere Balasubramanya et al. · Neoplasia · 2017 · 6.5K citations · Full text

, , +17

LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade

Wanqiang Sheng, Martin W. LaFleur, Thao H. Nguyen et al. · Cell · 2018 · 679 citations

, , +14

Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma

Mengxi Huang, Cheng Chen, Jian Geng et al. · Cancer Letters · 2017 · 144 citations

, , +14

Cost effectiveness of regorafenib as second‐line therapy for patients with advanced hepatocellular carcinoma

Neehar D. Parikh, Amit G. Singal, David W. Hutton · Cancer · 2017 · 83 citations · Full text

, , +14

Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer

Meng Li, Jingyu Yang, Wenlong Zhou et al. · British Journal of Cancer · 2017 · 77 citations · Full text

, , +17